MSB 2.08% 94.0¢ mesoblast limited

Ann: 83% Survival in COVID-19 ARDS Patients with Remestemcel-L, page-508

  1. 574 Posts.
    lightbulb Created with Sketch. 141
    What a great time to be a holder of MSB

    Two layman questions
    1) Where (or from what) do they source the stem cells ? (wondering if they soon need high volumes of stem cells then how easy are they to source)
    2) Will other providers of stem cell therapy similarly (perhaps with modification) be able to apply their technology also to Covid-19 sufferers ?
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
94.0¢
Change
-0.020(2.08%)
Mkt cap ! $1.073B
Open High Low Value Volume
95.5¢ 97.0¢ 93.5¢ $1.424M 1.507M

Buyers (Bids)

No. Vol. Price($)
8 29390 93.5¢
 

Sellers (Offers)

Price($) Vol. No.
94.5¢ 14089 2
View Market Depth
Last trade - 16.10pm 13/09/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.